| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.045 | 0.3 |